Lancet study: No statistically significant clinical benefits of remdesivir in COVID patients
In a study in the medical journal The Lancet, Chinese researchers have reported that they could not find any “statistically significant clinical benefits”.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario